Oraya Therapeutics Garners $15,875,000 Series C Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=89167852-3d0a-4fe1-9740-3bf4835c6d1f&Preview=1 - Date
4/5/2011 - Company Name
Oraya Therapeutics - Mailing Address
8000 Jarvis Ave Newark, CA 94560 - Company Description
Founded in 2006, Oraya is funded by Essex Woodlands Health Ventures, Synergy Life Science Partners, Scale Venture Partners, and Domain Associates. The company’s first commercial application, the IRay system, is currently undergoing clinical trials for the treatment of wet age-related macular degeneration (AMD). - Website
http://www.orayainc.com - Transaction Type
Venture Equity - Transaction Amount
$15,875,000 - Transaction Round
Series C - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Domain Associates - Venture Investor
Synergy Life Science Partners - Venture Investor
Essex Woodlands Health Ventures
